Related Experiment Video
Updated: Apr 26, 2026
05:39
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
931
Pediatric dermatology: past, present, and future.
Brea Prindaville1, Richard J Antaya, Elaine C Siegfried
1Department of Dermatology, Children's Mercy Hospital, Kansas City, Missouri.
Pediatric Dermatology
|July 22, 2014
Summary
Pediatric dermatology faces a significant provider shortage, leading to long wait times for children needing skin care. This review examines the specialty's history, challenges, and solutions to improve access.
Area of Science:
- Pediatric Dermatology
- Healthcare Workforce Studies
- Medical Education
Background:
- Skin conditions account for up to 30% of pediatric primary care visits.
- Pediatric dermatology is a severely underserved subspecialty with long appointment wait times.
- A persistent shortage of pediatric dermatologists limits access to specialized care for children.
Purpose of the Study:
- To review the historical development of pediatric dermatology.
- To identify obstacles hindering workforce expansion in pediatric dermatology.
- To propose solutions for improving access to pediatric skin care.
Main Methods:
- Literature review of the evolution of pediatric dermatology.
- Analysis of workforce challenges and training limitations.
- Exploration of potential strategies to address provider shortages.
Main Results:
- The subspecialty has evolved significantly but faces ongoing workforce deficits.
- Limited training opportunities exacerbate the shortage of pediatric dermatologists.
- Long wait times are a direct consequence of insufficient provider numbers.
Conclusions:
- Addressing the pediatric dermatology workforce shortage is critical for timely patient care.
- Expanding training pathways and implementing innovative solutions are necessary.
- Improving access to pediatric dermatologists will enhance care for children with skin diseases.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
400
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
400
01:14Changes in Skin Color: Clinical Perspectives
3.3K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.3K
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
954
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
954
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
405
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
405
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
547
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
547
01:27Acne Infection
91
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
91